Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies
Experts discuss the most common adverse events associated with trastuzumab deruxtecan, how to effectively identify and manage them to minimize treatment interruptions, and how to monitor and address interstitial lung disease (ILD), a known potential adverse effect of trastuzumab deruxtecan.
Video content above is prompted by the following:
• What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize treatment interruptions?
• How do you monitor and address ILD, a known potential adverse effect of trastuzumab deruxtecan?
Recent Videos
Related Content
